Circadian Rhythm of Glucose Uptake in Cultures of Skeletal Muscle Cells and Adipocytes in Wistar-Kyoto, Wistar, Goto-Kakizaki, and Spontaneously Hypertensive Rats

References

• Anlauf M., Baumgart P., Franz I. W., Kroenig B., Middekke M., Schrader J., Schulte K. L. Ambulante 24-Stunden-Blutdruckmessung (ABDM). Deut. Med. Wschr. 1998; 123: 1426–1430
   PubMedGoogle Scholar
• Balsalobre A., Marcacci L., Schibler U. Multiple signaling pathways elicit circadian gene expression in cultured Rat-1 fibroblasts. Current Biol. 2000; 10: 1291–1294, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Begum N., Ragolia L. Altered regulation of insulin signaling components in adipocytes of insulin-resistant type II diabetic Goto-Kakizaki rats. Metabolism 1998; 47: 54–62, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Boldin S., Jäger U., Ruppersberg J. P., Pentz S., Rüdel R. Cultivation, morphology, and electrophysiology of contractile rat myoballs. Pflügers Arch. Eur. J. Physiol. 1987; 409: 462–467, [CROSSREF]
   PubMedGoogle Scholar
• Braiman L., Sheffi-Friedman L., Bak A., Tennenbaum T., Sampson S. R. Tyrosine phosphorylation of specific protein kinase C isoenzymes participates in insulin stimulation of glucose transport in primary cultures of rat skeletal muscle. Diabetes 1999; 48: 1922–1929
   PubMedGoogle Scholar
• Brinkmeier H., van Mutz J., Markus J., Seewald M. J., Melzner I., Rüdel R. Specific modifications of the membrane fatty acid composition of human myotubes and their effects on the muscular sodium channels. Biochim. Biophys. Acta 1993; 1145: 8–14
   PubMedGoogle Scholar
• Caldiz C. I., de Cingolani G. E. Insulin resistance in adipocytes from spontaneously hypertensive rats: effect of long-term treatment with enalapril and losartan. Metabolism 1999; 48: 1041–1046, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Chen J. W., Jen S. L., Lee W. L., Hsu N. W., Lin S. J., Ting C. T., Chang M. S., Wang P. H. Differential glucose tolerance in dipper and nondipper essential hypertension: the implications of circadian blood pressure regulation on glucose tolerance in hypertension. Diabetes Care 1998; 21: 1743–1748, [CSA]
   PubMed Web of Science ®Google Scholar
• Epstein F. H. Glucose transporters and insulin action. Implications for insulin resistance and Diabetes mellitus. Review N. Engl. J. Med. 1999; 341: 248–257, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Farese R. V. Function and dysfunction of a PKC isoforms for glucose transport in insulin-sensitive and insulin-resistant states. Review. Am. J. Physiol. Endocrinol. Metab. 2002; 283: E1–E11, [CSA]
   PubMed Web of Science ®Google Scholar
• Fischer Y., Thomas J., Sevilla L., Munoz P., Becker C., Holman G., Kozka I. J., Palacin M., Testar X., Kammermeier H., Zorzano A. Insulin-induced recruitment of glucose transporter 4 (GLUT4) and GLUT1 in isolated rat cardiac myocytes. Evidence for the existence of different intracellular GLUT4 vesicle populations. J. Biol. Chem. 1997; 272: 7085–7092, [CROSSREF]
   PubMedGoogle Scholar
• Goff D.C., Jr., Zaccaro D. J., Haffner S. M., Saad M. F. Insulin sensitivity and the risk of incident hypertension: insights from the insulin resistance atherosclerosis study. Diabetes Care 2003; 26: 805–809, [CSA]
   PubMed Web of Science ®Google Scholar
• Gouveia L. M., Kettelhut I. C., Foss M. C. Abnormalities of glucose metabolism in spontaneously hypertensive rats. Braz. J. Med. Biol. Res. 2000; 33: 1357–1362, [CSA]
   PubMedGoogle Scholar
• Gschwend M. H., Rüdel R., Brinkmeier H., Taylor S. R., Föhr K. J. A transient and a persistent calcium release are induced by chlorocresol in cultivated mouse myotubes. Pflügers Arch. Eur. J. Physiol. 1999; 438: 101–106, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Harano Y., Suzuki M., Koyama Y., Kanda M., Yasuda S., Suzuki K., Takamizawa I. Multifactorial insulin resistance and clinical impact in hypertension and cardiovascular diseases. J. Diab. Compl. 2002; 16: 19–23, [CROSSREF]
   Google Scholar
• Hauner H. Insulin resistance and the metabolic syndrome—a challenge of the new millennium. Review. Eur. J. Clin. Nutrition 2002; 56(Suppl 1)S25–S29, [CROSSREF]
   Google Scholar
• Imazu M. Hypertension and insulin disorders. Curr. Hypertens. Rep. 2002; 4: 477–482, [CSA]
   PubMedGoogle Scholar
• Jarrett R. J. Temporal aspects of blood glucose regulation: implications for diabetic patients. Chronopharmacology, B. Lemmer. Marcel Dekker, New York, Basel 1989; pp. 615–620
   Google Scholar
• Kendall D. M., Harmel A. P. The metabolic syndrome, type 2 diabetes, and cardiovascular disease: understanding the role of insulin resistance. Am. J. Manag. Care 2002; 8(Suppl)S635–S657, [CSA]
   Google Scholar
• Krook A., Kawano Y., Song X. M., Efendic S., Roth R. A., Wallberg-Henriksen H., Zierath J. R. Improved glucose tolerance restores insulin-stimulated Akt kinase activity and glucose transport in skeletal muscle from diabetic Goto-Kakizaki rats. Diabetes 1997; 46: 2110–2114
   PubMedGoogle Scholar
• la Fleur S. E., Kalsbeek A., Wortel J., Fekkes M. L., Buijs R. M. A daily rhythm in glucose tolerance: a role for the suprachiasmatic nucleus. Diabetes 2001; 50: 1237–1243
   PubMed Web of Science ®Google Scholar
• Lemmer B. Differential effects of antihypertensive drugs on circadian rhythm in blood pressure from the chronobiological point of view. Blood Press. Monit. 1996; 1: 161–169
   PubMedGoogle Scholar
• Lemmer B., Portaluppi F. Chronopharmacology of cardiovascular diseases. Physiology and Pharmacology of Biological Rhythms. Handbook of Experimental Pharmacology, P. Redfern, B. Lemmer. Springer Verlag, New York, Berlin, Heidelberg 1997; Vol. 125: pp. 251–297
   Google Scholar
• Lemmer B., Mattes A., Böhm M., Ganten D. Circadian blood pressure variation in transgenic hypertensive rats. Hypertension 1993; 22: 97–101
   PubMed Web of Science ®Google Scholar
• Middeke M., Schrader J. Nocturnal blood pressure in normotensive subjects and those with white coat, primary, and secondary hypertension. Br. Med. J. 1994; 308: 630–632
   PubMed Web of Science ®Google Scholar
• Morgan L. M., Aspostolakou F., Wright J., Gama R. Diurnal variations in peripheral insulin resistance and plasma nonesterified fatty acid concentrations: a possible link?. Ann Clin. Biochem. 1999; 36: 447–450
   PubMed Web of Science ®Google Scholar
• Natalucci S., Ruggeri P., Cogo C. E., Picchio V., Burattini R. Insulin sensitivity and glucose effectiveness estimated by the minimal model technique in spontaneously hypertensive and normal rats. Exp. Physiol. 2000; 85: 775–781, [CSA]
   PubMedGoogle Scholar
• Nishitani S., Matsumura T., Fujitani S., Sonaka I., Miura Y., Yagasaki K. Leucine promotes glucose uptake in skeletal muscle of rats. Biochem. Biophys. Res. Commun. 2002; 299: 693–696, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Pravenec M., Zidek V., Musilova A., Simakova M., Kostka V., Mlejnek P., Kren V., Krenova D., Bila V., Mikova B., Jachymova M., Horky K., Kazdova L., Lezin E. S., Kurt T. W. Genetic analysis of metabolic defects in the spontaneously hypertensive rat. Mamm. Genome 2002; 13: 253–258, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Shin Y., Rika N., Abe M., Akiko H., Takahashi R., Ueda M., Block G. D., Sakaki Y., Menaker M., Tei H. Resetting central and peripheral circadian oscillators in transgenic rats. Science 2000; 288: 682–685, [CROSSREF]
   PubMedGoogle Scholar
• Spallone V., Maiello M. R., Cicconetti E., Pannone A., Barini A., Gambardella A., Mezinger G. Factors determining the 24-h blood pressure profile in normotensive patients with type 1 and type 2 diabetes. J. Hum. Hypertens. 2001; 15: 239–246, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Swislocki A. L., Goodman M. N., Khuu D. T., Fann K. Y. Insulin resistance and hypertension: in vivo and in vitro insulin action in skeletal muscle in spontaneously hypertensive and Wistar Kyoto rats. Am. J. Hypertens. 1997; 10: 1159–1164, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Swislocki A. L., LaPier T. L., Khuu D. T., Fann K. Y., Tait M., Rodnick K. J. Metabolic, hemodynamic, and cardiac effects of captopril in young, spontaneously hypertensive rats. Am. J. Hypertens. 1999; 12: 581–589, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Touitou Y., Portaluppi F., Smolensky M. H., Rensing L. Ethical principles and standards for the conduct of human and animal biological rhythm research. Chronobiol. Int. 2004; 21(1)161–170, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Tutdibi O., Brinkmeier H., Rüdel H., Föhr K. J. Increased calcium entry into dystrophin-deficient muscle fibres of MDX and ADR-MDX mice is reduced by ion channel blockers. J. Physiol. 1999; 515: 859–868, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Unwin N., Shaw J., Zimmer P., Alberti K. G. Impaired glucose tolerance and impaired fasting glycaemia: the current status of definition and intervention. Review. Diab. Med. 2002; 19: 708–723, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• WHO-ISH Guidelines Subcommittee. World Health Organization—International Society of Hypertension Guidelines for the Management of Hypertension. J. Hypertens. 1999; 17: 151–183
   PubMedGoogle Scholar
• Zizek B., Poredos B. Insulin resistance adds to endothelial dysfunction in hypertensive patients and in normotensive offspring of subjects with essential hypertension. J. Intern. Med. 2001; 249: 189–197, [CROSSREF]
   PubMedGoogle Scholar
• Zuther P., Lemmer B. WIN-ABPM-Fit—a comprehensive, rapid and easy-to-use program to analyze 24-h blood pressure data from humans and telemetric data from animals. Naunyn-Schmiedeberg's Arch. of Pharmacol. 2003; 367(Suppl 1)R124
   Google Scholar